Device Core Orthodontics

Clarity Advanced

Payments companies reported to CMS as associated with Clarity Advanced. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$777Kassociated payments (2023-2025)
819clinicians with associated payments
2companies reporting

By year

2023 $281K
2024 $272K
2025 $224K

Payments reported as associated with Clarity Advanced, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $754K
General Practice (Dentist) $15K
Dentist $4,813
Pediatric Dentistry $861
Oral and Maxillofacial Surgery $178
Oral and Maxillofacial Pathology $107

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Clarity Advanced

These are the largest totals companies reported as associated with Clarity Advanced. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Donna Stenberg Stillwater, MN Orthodontics and Dentofacial Orthopedics $688,978.84
Cranford Langley Daphne, AL Orthodontics and Dentofacial Orthopedics $8,307.52
Marc Geissberger Greenbrae, CA General Practice (Dentist) $8,266.75
Patrick O'Neil Daphne, AL Orthodontics and Dentofacial Orthopedics $8,199.26
Benjamin Samuelson Hoover, AL Orthodontics and Dentofacial Orthopedics $5,787.71
Megan Lecornu Santa Clarita, CA Orthodontics and Dentofacial Orthopedics $1,090.13
Douglas Palaganas Wantagh, NY Orthodontics and Dentofacial Orthopedics $1,000.00
Matthew Larson Altoona, WI Orthodontics and Dentofacial Orthopedics $750.00
Shaina Dimariano Folsom, CA General Practice (Dentist) $732.63
Charles Ankar Chattanooga, TN General Practice (Dentist) $667.87

Prescribed Clarity Advanced?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.